Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced in oligodendrocyte progenitor cells (1296 nCPM) | 1.00 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 55 | 0.91 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 11642
Sealed predictions
- ADARB2 in oligodendrocytes, braak-0.77 (p 0.015) → +0.19 (p 0.630)receipt 11650
- ADARB2 in dopamine neurons, braak-0.16 (p 0.685) → -0.30 (p 0.435)receipt 11651
Swarm cases
receipt 11651: ADARB2 in dopamine neurons, braak
- power
- full sample -0.29 (p 0.243, n 18), 95% CI -0.67 to +0.20. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.36 (p 0.145, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.44 (p 0.064, n 18). could be the mix.
- skeptic
- leave-one-out range -0.40 to -0.21, sign flips 0; without severely affected donors -0.29 (p 0.243, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADARB2 in dopamine neurons.
case closed: nothing better to follow up.
receipt 11650: ADARB2 in oligodendrocytes, braak
- power
- full sample -0.51 (p 0.032, n 18), 95% CI -0.79 to -0.05. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.52 (p 0.027, n 18). holds up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.51 (p 0.032, n 18). not the mix.
- skeptic
- leave-one-out range -0.64 to -0.45, sign flips 0; without severely affected donors -0.51 (p 0.032, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADARB2 in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts